EUVIMEDEUVIMED entdecken
Crossref

In Vivo Acute Toxicity and Therapeutic Potential of a Synthetic Peptide, DP1 in a Staphylococcus aureus Infected Murine Wound Excision Model

Panchali Barman, Chakshu Sharma, Shubhi Joshi, Sheetal Sharma, Mayank Maan, Praveen Rishi, Neha Singla, Avneet Saini

Probiotics and Antimicrobial Proteins · 2025-04 · 17 (2) · 843-856

DOI: 10.1007/s12602-023-10176-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 01.11.2023. Verfasst von Panchali Barman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Science and Criminology (UIEAST), Panjab University, Chandigarh, 160014, India. Hauptthemen laut MEDLINE: Staphylococcus aureus, Staphylococcal Infections, Anti-Bacterial Agents, Wound Infection. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Defence Research and Development Organisation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial infections at the surgical sites are one of the most prevalent skin infections that impair the healing mechanism. They account for about 20% of all types of infections and lead to approximately 75% of surgical-site infection-associated mortality. Several antibiotics, such as cephalosporins, fluoroquinolones, quinolones, penicillin, sulfonamides, etc., that are used to treat such wound infections not only counter infections but also disrupt the normal flora. Moreover, antibiotics, when used for a prolonged duration, may impair the formation of new blood vessels, delay collagen production, or inhibit the migration of certain cells involved in wound repair, leading to an impaired healing process. Therefore, there is a dire need for alternate therapeutic approaches against such infections. Antimicrobial peptides have gained considerable attention as a promising strategy to counter these pathogens and prevent the spread of infection. Recently, we have reported a designed peptide, DP1, and its broad-spectrum in vitro antimicrobial activity against Gram-positive and Gram-negative bacteria. In the present study, in vivo acute toxicity of DP1 was evaluated and even at a high dose (20 mg/kg body weight) of DP1, a 100% survival of mice was observed. Subsequently, a Staphylococcus aureus-infected murine wound excision model was established to assess the wound healing efficacy of DP1. The study revealed significant wound healing vis-a-vis attenuated S. aureus bioburden at the wound site and also controlled the oxidative stress depicting anti-oxidant activity as well. Healing of the infected wounds was also verified by histopathological examination. Based on the results of this study, it can be concluded that DP1 improves wound resolution despite infections and promotes the healing mechanism. Hence, DP1 holds compelling potential as a novel antimicrobial drug that requires further explorations in clinical platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsWound InfectionAntimicrobial PeptidesSurgical Wound InfectionPeptidesAnimalsMiceWound HealingDisease Models, AnimalFemaleMale

Stichwörter der Autor:innen

Staphylococcus aureusAcute toxicityAntimicrobial peptidesWound model

Substanzen

Anti-Bacterial AgentsAntimicrobial PeptidesPeptides

Autor:innen und Institutionen

  • Institute of Forensic Science and Criminology (UIEAST), Panjab University, Chandigarh, 160014, India.
  • Department of Biophysics, Panjab University, Chandigarh, U.T, 160014, India.
  • Department of Microbiology, Panjab University, Chandigarh, U.T, 160014, India.
  • Department of Biophysics, Panjab University, Chandigarh, U.T, 160014, India. avneet@pu.ac.in.

Förderung

  • Defence Research and Development Organisation

Zitieren

APA

Barman, P., Sharma, C., Joshi, S., Sharma, S., Maan, M., Rishi, P., Singla, N., & Saini, A. (2025). In Vivo Acute Toxicity and Therapeutic Potential of a Synthetic Peptide, DP1 in a Staphylococcus aureus Infected Murine Wound Excision Model. Probiotics and Antimicrobial Proteins, 17(2), 843-856. https://doi.org/10.1007/s12602-023-10176-1

Vancouver

Barman P, Sharma C, Joshi S, Sharma S, Maan M, Rishi P, et al. In Vivo Acute Toxicity and Therapeutic Potential of a Synthetic Peptide, DP1 in a Staphylococcus aureus Infected Murine Wound Excision Model. Probiotics and Antimicrobial Proteins. 2025;17(2):843-856. doi:10.1007/s12602-023-10176-1

BibTeX
@article{Barman2025,
  author = {Barman, Panchali and Sharma, Chakshu and Joshi, Shubhi and Sharma, Sheetal and Maan, Mayank and Rishi, Praveen and Singla, Neha and Saini, Avneet},
  title = {In Vivo Acute Toxicity and Therapeutic Potential of a Synthetic Peptide, DP1 in a Staphylococcus aureus Infected Murine Wound Excision Model},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {843--856},
  doi = {10.1007/s12602-023-10176-1}
}
Kostenlos starten →